Viking Therapeutics remains a compelling obesity drugs contender, despite being in the pre-commercial phase. VKTX's ...
A new study suggests that most parents don't know how to read the charts and may think a child's weight is perfectly fine, when, in fact, the child is obese ...
Times today increasingly oscillate between desks, screens and supermarkets, which has become a creeping health concern.
News-Medical.Net on MSN
Imaging-enhanced knowledge graphs reveal new targets for heart disease treatment
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...
The Danish drugmaker hopes the new oral version could revive its fortunes, with its share price and profits flagging in the ...
4don MSN
RFK Jr, Trump upend US food chart in MAHA shake-up: Federal diet shock leaves doctors furious
The U.S. government has unveiled sweeping revisions to its Dietary Guidelines for Americans, emphasizing protein, whole foods ...
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...
While rates of cancer diagnosis under age 50 have risen in recent years, this has not translated into increased cancer ...
Through its commitment to a data-driven approach to improving cardiovascular health, the Journal of the American College of ...
“My energy has returned to a level that I never expected to see again, and the difference in my appearance and energy have ...
Zacks Investment Research on MSN
Will NVO's Wegovy pill approval for obesity be a game changer in 2026?
Last month, Novo Nordisk NVO announced the FDA approval of the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results